Current advisor: Kenneth M. Murphy, MD, PhD
Undergraduate university: New York University
Dendritic cells (DCs) functions to bridge innate and adaptive immunity by mediating the activity of various effector cells. The two branches of DCs consists of plasmacytoid DCs (pDCs) and classical DCs (cDCs), of which can be further subdivided into cDC1s and cDC2s. cDC1s are uniquely important in response against intracellular pathogens and tumors due to their ability to cross-present antigens. My work in the Murphy lab will seek to better understand DC development—specifically the molecular genetic circuitries and transcriptional requirements driving lineage-differentiation.
Ferris ST, Ohara RA, Ou F, Wu R, Huang X, Kim S, Chen J, Liu TT, Schreiber RD, Murphy TL, Murphy KM. 2022 cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1. Cancer Immunol Res, ():canimm.0865.2021.
Huang X, Ferris ST, Kim S, Choudhary MNK, Belk JA, Fan C, Qi Y, Sudan R, Xia Y, Desai P, Chen J, Ly N, Shi Q, Bagadia P, Liu T, Guilliams M, Egawa T, Colonna M, Diamond MS, Murphy TL, Satpathy AT, Wang T, Murphy KM. 2021 Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesis. Immunity, 54(7):1417-1432.e7.